2-(2-chloro-5-methoxyphenyl)ethan-1-amine | 882674-30-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-chloro-5-methoxyphenyl)ethan-1-amine
• 英文别名: 2-(2-chloro-5-methoxyphenyl)ethanamine
• CAS: 882674-30-8
• 化学式: C₉H₁₂ClNO
• 分子量: 185.653
• InChiKey: CIJBYFPAVIDZBV-UHFFFAOYSA-N

物化性质

• 沸点：
  280.5±25.0 °C(Predicted)
• 密度：
  1.146±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(2-chloro-5-methoxyphenyl)ethan-1-amine 在 吡啶 作用下， 以 氯仿 为溶剂， 反应 6.5h， 生成 2-[2-({[2-(2-chloro-5-methoxyphenyl)ethyl]amino}carbonyl)phenyl]ethyl ethyl carbonate
  参考文献：
  名称：

  Dopamine/Serotonin Receptor Ligands. 12:  SAR Studies on Hexahydro-dibenz[d,g]azecines Lead to 4-Chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the First Picomolar D₅-Selective Dopamine-Receptor Antagonist

  摘要：

  Hydroxylated, methoxylated, and/or chlorinated 7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecines were generally synthesized out of substituted 2-phenylethylamines and isochromanones by Bischler-Napieralski cyclization of the resulting benzamides to dibenzoquinolizines and the quaternization and cleavage of the central C-N bond under Birch conditions. Chlorination of 2-phenylethylamines was useful for the site direction of cyclization, but chlorine atoms were removed under Birch conditions so that chlorination had to be repeated to get the respective chlorinated dibenz[dg]azecines. The target compounds were tested for their affinity at the different human-cloned dopamine-receptor subtypes (D-1 family, D-2 family). Generally, hydroxylation and chlorination of the dibenz-azecines increased affinities significantly. 1-Chloro-2-hydroxyhexahydro-dibenz[d,g]azecine was a subnanomolar antagonist at both subtype families. 4-Chloro-3-hydroxy7-methyl-5,6,7,8,9,14-hexahydro-dibenz[d,g]azecine was identified as the most potent and selective dopamine D-5 receptor ligand described to date with K-i(D-1) = 0.83, K-i(D-2L) = 4.0, K-i(D-3) = 24.6, K-i(D-4) = 5.2 nM, and K-i(D-5) = 57 pM (radioligand binding experiments), respectively.

  DOI：

  10.1021/jm051237e
• 作为产物：
  描述：

  苯乙腈 在 盐酸 作用下， 以 四氢呋喃 为溶剂， 生成 2-(2-chloro-5-methoxyphenyl)ethan-1-amine
  参考文献：
  名称：

  Tetraisoquinoline compounds which have useful pharmaceutical utility

  摘要：

  四氢异喹啉化合物的化学式为I ##STR1##，其药用盐和亲脂性酯具有镇痛作用，并可用于治疗精神病、帕金森病、莱施-尼恩综合征、注意力缺陷障碍或认知障碍，以及缓解药物依赖或迟发性运动障碍。

  公开号：

  US05519034A1

文献信息

• [EN] THERAPEUTIC COMPOUNDS<br/>[FR] COMPOSÉS THÉRAPEUTIQUES
  申请人：C4X DISCOVERY LTD

  公开号：WO2020084300A1

  公开（公告）日：2020-04-30

  The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.

  本发明涉及一类能激活Nrf2的化合物。这些化合物具有本文中定义的结构式I。本发明还涉及制备这些化合物的方法，包括含有它们的药物组合物，以及它们在治疗与Nrf2激活相关的疾病或疾病中的应用。
• Tetrazanbigen Derivatives as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Partial Agonists: Design, Synthesis, Structure–Activity Relationship, and Anticancer Activities
  作者：Linling Gan、Zongjie Gan、Yanrong Dan、Yaowei Li、Peiming Zhang、Shanwen Chen、Zaijun Ye、Tao Pan、Chunmei Wan、Xuelian Hu、Yu Yu

  DOI：10.1021/acs.jmedchem.0c01512

  日期：2021.1.28

  be explained by the partial activation and upregulation of PPARγ expression, as indicated by the transactivation assay and western blotting evaluation. Furthermore, the in vitro antiproliferative activity was verified in an in vivo xenograft model in which 14g strongly reduced tumor growth at a dose of 10 mg/kg. In line with these positive observations, 14g exhibited an excellent water solubility of

  Tetrazanbigen（TNBG）是一种新型的固醇异喹啉衍生物，其水溶性差，并且通过脂质凋亡诱导对人癌细胞系具有中等抑制作用。本文中，我们开发了一系列具有改善的水溶性和抗增殖活性的新型TNBG类似物。CCK-8分析使我们能够鉴定出一种新型化合物14g，该化合物强烈抑制HepG2和A549细胞的生长，IC 50值分别为0.54和0.47μM。如反式激活分析和蛋白质印迹评估所示，抗癌作用可以通过PPARγ表达的部分激活和上调来解释。此外，体外在体内异种移植模型中验证了抗增殖活性，其中14g以10 mg / kg的剂量强烈降低了肿瘤的生长。与这些积极的观察一致，14g的水溶性极好，为31.4 mg / mL，比TNBG（4μg / mL）高出1000倍以上。总之，这些结果表明14g是一种有前途的抗癌治疗药物，值得进一步研究。
• Substituted carbonucleoside derivatives useful as anticancer agents
  申请人：Pfizer Inc.

  公开号：US10220037B2

  公开（公告）日：2019-03-05

  Compounds of the general formula): processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

  通式）的化合物： 这些化合物的制备工艺、含有这些化合物的组合物以及这些化合物的用途。
• TW2018/2074
  申请人：——

  公开号：——

  公开（公告）日：——
• SUBSTITUTED TETRAHYDROISOQUINOLINES AND THEIR USE AS THERAPEUTIC AGENTS
  申请人：The Boots Company PLC

  公开号：EP0618900A1

  公开（公告）日：1994-10-12